Key Takeaway: QIAGEN N.V. has appointed Jonathan M. Pratt as the new CEO, effective September 1, 2026. Pratt has over 25 years of international leadership experience in life sciences, laboratory technologies, and healthcare. His previous role was as President and CEO of the Filtration Group, where he successfully led the company.
Market Sentiment Analysis
POSITIVE FACTORS
Jonathan M. Pratt brings over 25 years of leadership experience.
His background includes expertise in Life Sciences and healthcare.
The appointment is expected to strengthen QIAGEN's leadership.
Full Press Release Details
Venlo, Niederlande--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Ernennung von Jonathan M. Pratt zum Vorstandsvorsitzenden mit Wirkung zum 1. September 2026 bekannt gegeben. Er bringt mehr als 25 Jahre internationale Führungserfahrung in den Bereichen Life Sciences, Labortechnologien und Gesundheitswesen ins Unternehmen ein. Jon Pratt war zuletzt Präsident und Vorstandsvorsitzender der Filtration Group und führte das Unternehmen bis zum Abschluss des Ve
Frequently Asked Questions
Who has been appointed as the new CEO of QIAGEN?
Jonathan M. Pratt has been appointed as the new CEO of QIAGEN.
When will Jonathan M. Pratt officially start as CEO?
He will officially start as CEO on September 1, 2026.
What experience does Jonathan M. Pratt bring?
He brings over 25 years of international leadership experience.
What was Jonathan M. Pratt's previous role?
He was the President and CEO of the Filtration Group.